Veytics Intelligence
2026-10-28 · Yahoo

Update: Eli Lilly Says Retatrutide Delivers Greater Weight Loss Than Ozempic in Adults With Type 2 Diabetes

(Updates with Novo Nordisk's comments in the last two paragraphs.) Eli Lilly (LLY) said Wednesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in

Przeczytaj pelny brief Veytics

Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.